What is real-time prescription monitoring (RTPM)? | IMM

What is real-time prescription monitoring (RTPM)?

How real-time monitoring systems prevent medication misuse and protect your claimants.

Published: 3 April 2026 | Updated: 3 April 2026

The Technology Behind Real-Time Prescription Monitoring

Real-time prescription monitoring systems track medication prescriptions as they're dispensed, creating a live database that prescribers and pharmacists can access instantly. When a doctor considers prescribing medication to your claimant, they check the monitoring system and see what medications your claimant has been prescribed recently, from which prescribers, and in what quantities. This information appears in real time (or near-real time), allowing prescribers to make informed decisions about whether the prescription is appropriate.

In Australia, the primary real-time monitoring system is SafeScript, implemented in Victoria and other states. New South Wales uses QScript. These systems are specifically designed to prevent medication misuse, doctor shopping (visiting multiple doctors to obtain excessive medication), and harmful medication combinations.

For your insurance claims, RTPM systems are powerful tools for identifying and preventing medication misuse before it creates claim complications.

Key benefit for insurers: RTPM systems prevent your claimants from obtaining multiple prescriptions for the same medication from different prescribers, prevent accumulation of high-dose opioids and benzodiazepines, and alert prescribers to dangerous medication combinations. This reduces overdose risk, addiction risk, and medication-related complications in your claims.

How SafeScript Works in Victoria

SafeScript is Victoria's real-time prescription monitoring system. When a doctor writes a prescription for specified medications (primarily opioids, benzodiazepines, and certain other controlled or high-risk medications), the prescription is transmitted to SafeScript. The system stores information about the medication, dose, quantity, prescriber, and date.

When another doctor is considering prescribing medication to the same patient, they can (and in many cases must) check SafeScript to see recent prescriptions. The system provides visibility into what medications the patient is already receiving, preventing the prescriber from prescribing duplicates or dangerous combinations without awareness.

SafeScript also generates alerts. If a patient has recently received multiple opioid prescriptions from different prescribers, SafeScript flags this pattern. If a patient is on a dangerous combination of medications (opioid plus benzodiazepine, for example), SafeScript alerts the prescriber.

Importantly, SafeScript applies specifically to Schedule 8 controlled drugs (like strong opioids, benzodiazepines, and stimulants) and some Schedule 4 medications. Not all medications are monitored. But the drugs most likely to be misused are tracked in real time.

How QScript Works in New South Wales

QScript is New South Wales' comparable system with similar functionality to SafeScript. Prescribers check QScript before writing prescriptions for restricted medications. The system provides real-time visibility into what medications the patient has received recently, allowing prescribers to identify problematic patterns before they become serious.

Like SafeScript, QScript specifically focuses on controlled and high-risk medications. General medications used for common conditions aren't monitored through QScript. But opioids, benzodiazepines, and other high-risk drugs are tracked.

What RTPM Systems Prevent

Doctor Shopping

Doctor shopping occurs when a patient visits multiple prescribers, obtaining prescriptions from each without any single prescriber knowing about the others' prescriptions. Your claimant sees the pain specialist and gets opioids. Then visits the GP and gets more opioids. Then sees an urgent care clinic and gets more. No single prescriber realizes the patient is accumulating dangerous quantities. RTPM systems make this pattern visible. When the third prescriber checks the monitoring system, they see that the patient already has two active opioid prescriptions and can refuse the third.

Medication Accumulation

Even without intentional doctor shopping, medication can accumulate. Your claimant was prescribed benzodiazepine by a psychiatrist. Their anxiety improved, but they didn't stop the medication. Months later, they're prescribed a second benzodiazepine by a different doctor for insomnia. That prescriber didn't know about the first. RTPM systems alert the second prescriber to the existing benzodiazepine, allowing them to reconsider the prescription or adjust the approach.

Drug-Seeking Behavior

Some patients actively seek to obtain medications through manipulative behavior, exaggerating symptoms or visiting multiple providers. RTPM systems provide objective data about what medications a patient is already receiving, making it harder to convince a prescriber that additional medication is needed when they can see the patient is already on substantial quantities.

Dangerous Combinations

The opioid-benzodiazepine combination is particularly dangerous, with high overdose risk. RTPM systems flag when this combination is present. A prescriber considering prescribing a benzodiazepine to a patient already on opioids sees a safety alert from the monitoring system, prompting reconsideration.

Medication Class SafeScript Monitored QScript Monitored Risk Profile
Strong Opioids Yes (Schedule 8) Yes (Schedule 8) High: overdose, addiction
Benzodiazepines Yes (Schedule 8) Yes (Schedule 8) High: addiction, falls, overdose with opioids
Stimulants Yes (Schedule 8) Yes (Schedule 8) Moderate: abuse potential
Z-drugs (zopiclone) Some; Schedule 4 Yes Moderate: addiction, falls
General medications No No Low to moderate

RTPM and Insurance Claims

Real-time monitoring systems directly impact your claims in several ways. First, they prevent medication misuse complications. Your claimant can't accumulate excessive opioids or benzodiazepines without a prescriber or pharmacist noticing. This reduces overdose risk, reduces addiction risk, and prevents some of the serious medication-related complications that drive claim costs.

Second, RTPM systems create documentation. When prescribers check the monitoring system before writing prescriptions, a record exists. If your claimant later claims they weren't aware they were accumulating medications, the prescriber's documented check of the monitoring system shows the prescriber had the information available.

Third, RTPM systems alert pharmacists. When a pharmacist receives a prescription, they can verify it against the monitoring system. If a prescription seems inconsistent with what's already prescribed (e.g., a very high dose when the patient is already on other high-dose medications), the pharmacist can query it before dispensing.

RTPM systems haven't eliminated medication misuse, but they've dramatically reduced doctor shopping and dangerous accumulation of high-risk medications. They're a powerful safeguard in your claims, preventing many medication-related complications before they occur.

Limitations of RTPM

While powerful, RTPM systems have limitations your claims team should understand. First, they only monitor specific medications, primarily Schedule 8 controlled drugs. A patient can still accumulate Schedule 4 or non-scheduled medications without appearing in the monitoring system. A claimant could be prescribed high-dose antidepressants, high-dose anticonvulsants, and high-dose pain medications from different prescribers, and this wouldn't necessarily trigger any RTPM alert because these aren't on the monitored list.

Second, RTPM systems work only if prescribers actively check them. Some prescribers consistently check before prescribing. Others less diligently. If a prescriber simply writes a prescription without checking the monitoring system, the system's protective benefit is lost.

Third, patients and their caregivers can access the monitoring systems themselves in some jurisdictions, which is good for transparency but also means patients can use this information to identify which prescribers to visit to avoid overlapping prescriptions being detected.

Fourth, interstate prescribing might fall outside the system. A claimant prescribed opioids in Victoria by SafeScript but visits a provider in another state might be able to obtain additional opioids without SafeScript visibility.

Medication Review with RTPM Integration

A comprehensive medication review incorporates RTPM data. Our pharmacists check SafeScript and QScript to see the complete, real-time picture of what medications your claimant is receiving. We assess whether any dangerous combinations are present, whether accumulation is occurring, and whether the total medication burden is appropriate. This integration of monitoring data with clinical judgment provides the most complete assessment.

Real-World Insurance Scenarios

Scenario One: SafeScript Prevents Doctor Shopping

Your claimant with chronic pain has been prescribed opioids by a pain specialist. Four months in, they visit their GP complaining of increased pain and requesting stronger medication. The GP checks SafeScript before prescribing and sees that the claimant is already on a substantial opioid dose from the specialist. The GP doesn't prescribe additional opioids. Instead, they contact the pain specialist to discuss the claimant's worsening pain. It turns out the claimant's condition has changed, and a different approach (non-opioid) is more appropriate. SafeScript prevented problematic escalation.

Scenario Two: Pharmacist Alert Catches Dangerous Combination

Your claimant's psychiatrist prescribes a benzodiazepine for anxiety. When the claimant presents the prescription to the pharmacist, the pharmacist checks QScript and sees the claimant is already on a strong opioid for pain. The pharmacist alerts the claimant to the danger of combining opioids and benzodiazepines and contacts the prescriber. The psychiatrist wasn't aware of the opioid. The benzodiazepine is adjusted to a lower dose, or an alternative medication is chosen. A serious adverse event is prevented.

Scenario Three: RTPM Data Informs Medication Review

Your claimant is referred for medication review. The pharmacist checks SafeScript and sees multiple opioid prescriptions from different providers over the past six months, plus benzodiazepines, plus sedating antidepressants. While no single medication was prescribed maliciously, the combination is concerning. The review recommends consolidating the opioid to a single prescriber, ceasing the benzodiazepine in favor of alternative anxiety management, and adjusting the antidepressant dose. RTPM visibility makes the medication burden apparent and drives needed consolidation.

RTPM and Your Claimants

SafeScript and QScript are valuable safeguards for your claimants. But they work best when prescribers consistently check them and when comprehensive medication reviews consolidate the medication picture. If your claimant is on multiple high-risk medications, a medication review that integrates RTPM data provides visibility and allows for optimization.

The Bottom Line

Real-time prescription monitoring systems like SafeScript and QScript prevent medication misuse, doctor shopping, and dangerous medication combinations. They create visibility into what medications your claimants are receiving across multiple prescribers. This protects your claimants from overdose, addiction, and medication-related complications. They also protect your claims by preventing some of the most costly medication-related adverse events. While RTPM has limitations, it's a powerful tool in your medication risk management arsenal.

Leverage monitoring data in your medication reviews.

If your claimants are on Schedule 8 medications or other high-risk drugs, their prescribing should be monitored through SafeScript, QScript, or equivalent systems. IMM's medication reviews integrate real-time monitoring data to identify and prevent dangerous medication combinations and misuse patterns.

Request a Medication Review

This article was prepared by the clinical pharmacy team at IMM (Independent Medication Management), Australia's specialist provider of medication reviews for the insurance industry. IMM works with insurers across workers compensation, CTP, life insurance, and NDIS schemes to deliver pharmacist-led medication management that improves claimant outcomes and reduces medication-related risk. Learn more about IMM's services.

Evidence-Based Medication Oversight for Better Claim Outcomes

Expert pharmacy reviews and medication management services that help claims teams make confident, informed decisions about medication-related claims.

Got Questions? Speak to an Independent Pharmacist

Unbiased advice on your claimant's medications and recovery plan.